Skip to Content

93 7530 (Metformin hydrochloride and rosiglitazone maleate 500 mg / 1 mg)

Pill with imprint 93 7530 is Yellow, Elliptical / Oval and has been identified as Metformin hydrochloride and rosiglitazone maleate 500 mg / 1 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Metformin/rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/rosiglitazone 500 mg / 1 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 93 7530

Metformin hydrochloride and rosiglitazone maleate

Imprint:
93 7530
Strength:
500 mg / 1 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide